BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Ionis Pharma Licenses IONIS-HTT Rx to Partner Following Successful Phase I/II Study in Patients With Huntington’s Disease

  Roche will now be responsible for all development and commercial activities.

  December 11, 2017

   · 

  7 min read
• Policy

  Prometic’s PBI-4050 Receives Promising Innovative Medicine (PIM) Designation From the UK MHRA in the Treatment of Idiopathic Pulmonary Fibrosis

  ProMetic Life Sciences announced today that its orally-active drug candidate, PBI-4050, has been issued a Promising Innovative Medicine designation by the UK MHRA as add-on treatment to nintedanib in patients with idiopathic pulmonary fibrosis.

  December 11, 2017

   · 

  5 min read
• Policy

  Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA (aflibercept) Injection for Patients With Wet AMD

  Under the PDUFA, the goal for a standard review of an sBLA is ten months from submission for a target action date of August 11, 2018.

  December 11, 2017

   · 

  10 min read
• Business

  Medigene Collaborates With RXi Pharma to Further Sharpen its Therapeutic T cells

  The preclinical research program will examine the applicability of RXi’s sd-rxRNA technology to be integrated into Medigene’s process to produce receptor-modified T cells with the ultimate goal to further improve Medigene’s T cell therapies for the treatment of cancer patients.

  December 11, 2017

   · 

  6 min read
• Business

  Radient Technologies Announces Master Services Agreement With Terra Life Sciences

  Radient Technologies Inc. announces the signing of a Master Services Agreement to produce cannabis extracts for the Terra Life Sciences group.

  December 11, 2017

   · 

  3 min read
• Genetown

  Pillar Biosciences Announces Issuance of China and U.S. Patents Covering SLIMamp Technology

  The SIPO of the People’s Republic of China issued patent ZL201680001111.1 with a duration of 20 years.

  December 11, 2017

   · 

  2 min read
• Biotech Beach

  Regen BioPharma Files Additional Composition of Matter Patent Application on NR2F6-Modulating Small Molecules

  Regen BioPharma today announced filing a patent application covering composition of matter and methods of use related to molecules identified in its small molecule program that activate and inhibit NR2F6.

  December 11, 2017

   · 

  2 min read
• Drug Development

  Sophiris Bio Announces Complete Enrollment in Phase IIb Topsalysin Study of Localized Prostate Cancer

  Sophiris Bio today announced that it has completed enrollment in its Phase 2b study to evaluate the safety and tolerability of topsalysin in treating men with clinically significant localized prostate cancer.

  December 11, 2017

   · 

  6 min read
• Business

  MilliporeSigma Signs Distribution Agreement With Avanti Polar Lipids

  Under the terms of the agreement, MilliporeSigma will employ its sales, marketing and e-commerce expertise to distribute Avanti Polar Lipid’s research lipid portfolio.

  December 11, 2017

   · 

  3 min read
• Pharm Country

  OncoTartis Closes $6M Financing Round

  OncoTartis has concluded a $6M financing round to support the Phase 1 clinical trial of its lead drug candidate, OT-82.

  December 11, 2017

   · 

  2 min read